Volume 28, No 6, Jun 2018

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 28 Issue 6, June 2018: 611-612

RESEARCH HIGHLIGHTS

Aberrant erythropoiesis fuels tumor growth

Kyohei Nakamura ¹ and Mark J. Smyth ¹

¹Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston 4006 QLD, Australia
Correspondence: Correspondence: Mark J. Smyth (mark.smyth@qimrberghofer.edu.au)

Tumor-induced aberrant myelopoiesis is known to induce immunosuppressive myeloid cells in cancer patients. Han et al. reveal that tumor-induced spleen erythroblast-like cells, called Ter-cells, promote tumor growth via secretion of a neurotropic factor, artemin, providing evidence that altered erythropoiesis also directly contributes to tumor progression.

https://doi.org/10.1038/s41422-018-0047-1

FULL TEXT | PDF

Browse 1054